Prognostic Outcomes of Signet Ring Cell Carcinoma of the Breast
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Journal of Surgical Research
- Vol. 264, 138-148
Abstract
No abstract availableKeywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR001436)
- National Institutes of Health (UL1TR001436)
This publication has 28 references indexed in Scilit:
- Compliance and persistence of endocrine adjuvant breast cancer therapyBreast Cancer Research and Treatment, 2011
- Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the LungJournal of Thoracic Oncology, 2010
- Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast CancerJAMA, 2006
- Immunohistochemical Characterization of Signet-Ring Cell Carcinomas of the Stomach, Breast, and ColonAmerican Journal of Clinical Pathology, 2004
- Immunohistochemical Characterization of Signet-Ring Cell Carcinomas of the Stomach, Breast, and ColonAmerican Journal of Clinical Pathology, 2004
- Early diagnosis of signet ring cell carcinoma of the stomach: role of the Genta stain.Journal of Clinical Pathology, 1997
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy studyJournal of Surgical Oncology, 1991
- Adenocarcinoma of urinary bladder: Classification and managementUrology, 1991
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987